Women were less than half of the people tested for almost all of these common medicines.
PregnancyCommunity forum

NCT03185065

Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple Sclerosis

See it on ClinicalTrials.gov ↗

141 people

109 womenmiddle line = equal numbers32 men
Phase
PHASE3
Paid for by
Johns Hopkins University
Finished
2019-11-21
Health conditions
Fatigue in Multiple Sclerosis
Who could join
Anyone
Ages
18 Years – no maximum
Average age
mean 46.8 years
Age 65+
Not reported
Weight (BMI)
Not reported
Pregnancy recorded
Not reported
Menopause recorded
Not reported
Results shown by sex
Not split by sex
Race
White 75.9% · Black / African American 13.5% · Not reported 10.6% · American Indian / Alaska Native 0% · Asian 0% · Native Hawaiian / Pacific Islander 0% · More than one race 0%

Women left out

  • No pregnant women

    Women who were pregnant could not join.

    “Breastfeeding or pregnant.”
  • No breastfeeding moms

    Women who were breastfeeding could not join.

    “Breastfeeding or pregnant.”
  • Had to use birth control

    Women who couldn't or didn't want to use birth control were turned away.

    “Females of childbearing age must have a negative urine pregnancy test at baseline and use an effective method of contraception during the study.”
  • No heart disease

    Women with heart disease, heart rhythm problems or a past heart attack were turned away.

    “History of coronary artery disease or congestive heart failure.”
  • No mental health conditions

    Women with depression, bipolar disorder or other mental health conditions were turned away.

    “Clinically unstable medical or psychiatric disorders that require acute treatment as determined by the PI.”
  • No cancer

    Women with current or past cancer were turned away.

    “Currently treated for active malignancy.”

Study titles and rules are shown in their original English.